Project
Title
|
Funding Source
|
Amount (£)
|
Period
|
PI
|
|
|
|
GBA mutations
and Parkinson disease: Molecular mechanisms and Therapeutic intervention
|
Parkinson's UK
|
319,324
|
2017-2020
|
Tony Schapira
|
|
|
|
TIG-B project
plan no. 4
|
Eisai Ltd
|
756,955
|
2014-2018
|
Tony Schapira
|
|
|
|
Glucocerebrosidase
mutations in Parkinson disease: molecular pathogenesis, and the basis for
personalised therapy with small molecule chaperones
|
MRC
|
934,952
|
2015-2019
|
Tony Schapira
|
|
|
|
Glucocerebrosidase
chaperones in Parkinson disease
|
Parkinson's UK
|
307,081
|
2015-2018
|
Tony Schapira
|
|
|
|
SYSMEDPD -
systems medicine of mitochondrial Parkinson's disease
|
EC Horizon 2020
|
389,986
|
2015-2019
|
Tony Schapira
|
|
|
|
GBA1
mutations in Parkinson disease; Clinical and biochemical prodrome risk
profile pathogenetic modelling for therapeutic intervention
|
JPND /MRC
|
297,289
|
2016-2019
|
Tony Schapira
|
|
|
|
Ambroxol in
the modification of PD progression (AIM-PD)
|
Cure Parkinson's
Trust
|
321,750
|
2016-2018
|
Tony Schapira
|
|
|
|
|
Royal Embassy of
Saudi Arabia Cultural Bureau
|
198,507
|
2015-2019
|
Tony Schapira
|
|
|
|
Understanding
and predicting parkinson's progression
|
Parkinson's UK
|
99,169
|
2017-2020
|
Huw Morris
|
|
|
|
A
longitudinal clinical and biomarker study of Progressive Supranuclear Palsy
and Cortico-Basal Syndrome (PSP Research Network)
|
PSP Association
|
294,808
|
2014-2018
|
Huw Morris
|
|
|
|
Development
of CSF biobank and CSF biomarkers for PSP
|
PSP Association
|
184,697
|
2015-2019
|
Huw Morris
|
|
|
|
Sara Koe
Research Fellowship (sponsor)
|
PSP Association
|
228,208
|
2015-2019
|
Huw Morris
|
|
|
|
European
registry and longitudinal study of Cortico-Basal Syndrome
|
CBD Solutions
|
305,456
|
2014-2017
|
Huw Morris
|
|
|
|
Strategic
biomarkers initiative project
|
NIHR Biomedical
Research Centre
|
66,330
|
2015-2018
|
Huw Morris
|
|
|
|
A
longitudinal biomarker study of sports related head injury and outcomes
|
Drake Foundation
|
500,000
|
2015-2019
|
Huw Morris
|
|
|
|
A
participant's guide to userfriendly information in genetic research -
institutional strategic support fund
|
Welcome Trust
|
1,498
|
2015-2018
|
Huw Morris
|
|
|
|
Create a
nested CPT resource with the CANDAS biobank using the CANDAS consent to store
genetic data from PD-STAT
|
Cure Parkinson's
Trust
|
45,000
|
2016-2019
|
Huw Morris
|
|
|
|
|
NIHR Biomedical
Research Centre
|
47,789
|
2016-2018
|
Huw Morris
|
|
|
|
European
Multicentre Tics and Streptococcal Infections Study (EMTICS)
|
EU Commission FP7
|
111,302
|
2011-2018
|
Anette Schrag
|
|
|
|
How commonly
is late onset depression a manifestation of prodromal Parkinson’s
disease/Lewy body disease?
|
GE Healthcare UK Ltd
|
105,000
|
2013-2018
|
Anette Schrag
|
|
|
|
Royal Free
Parkinson'sPPI Research Group, institutional strategic support fund
|
Welcome Trust
|
550
|
2015-2018
|
Anette Schrag
|
|
|
|
Care of Late
Stage Parkinsonism
|
JPND
|
252,403
|
2014-2018
|
Anette Schrag
|
|
|
|
Developmnent
of IMPDS , of a new comhrehensive,parkinson's NON Motor Symptoms scale
|
Inter. Parkinson's
and Movement Disorders Society
|
77,376
|
2015-2018
|
Anette Schrag
|
|
|
|
PREDICT-PD
Parkinson’s UK
|
Parkinson's UK
|
594,111
|
2017-2021
|
Anette Schrag
|
|
|
|
S/SHIP
analysis of Tau release from cells in exosoms: potential role in the spread
of Tau pathology
|
Alzheimer's Society
|
91,000
|
2015-2018
|
Mark Cooper
|
|
|
|
Mitochondrial
Biogenesis and disease
|
MRC Senior
Non-Clinical Fellowship
|
1,042,186
|
2016-2019
|
Antonella Spinazzola
|
|
|
|
Detailed
investigation of SNCA CNV mosaicism in Parkinson's disease
|
MJF Foundation
|
130,444
|
2018-2019
|
Christos Proukakis
|
|
|
|
|
TOTAL
|
7,703,171
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|